Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA

NCT07400341 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

MDS (Myelodysplastic Syndrome)
Aplastic Anemia (AA)

Interventions

DRUG: Romiplostim
DRUG: Recombinant Human Thrombopoietin

Sponsor

The First Affiliated Hospital of Soochow University